<?xml version="1.0" encoding="UTF-8"?>
<p>SARS‐CoV‐2 is a novel virus and shares a 79.0% nucleotide identity with the sequence of SARS‐CoV and a 51.8% identity with that of MERS‐CoV.
 <xref rid="jmv25749-bib-0034" ref-type="ref">
  <sup>34</sup>
 </xref> Therefore, the risk of vertical transmission of COVID‐19 may be similar to SARS‐CoV and MERS‐CoV. A study in Hong Kong investigated 12 pregnant women with SARS and showed that all five newborn infants were negative for SARS, especially three of which who were delivered in the acute stage of maternal SARS infection and faced serious risks of perinatal infection.
 <xref rid="jmv25749-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref> Another article reported a pregnant woman with MERS in which all laboratory results related to MERS‐CoV in the newborn were negative, as well as that of the cord blood and placenta.
 <xref rid="jmv25749-bib-0036" ref-type="ref">
  <sup>36</sup>
 </xref>
</p>
